San Diego, CA -- (SBWire) -- 04/28/2021 --An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Northwest Biotherapeutics, Inc.
Investors who purchased shares of Northwest Biotherapeutics, Inc. (OTC: NWBO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Northwest Biotherapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Bethesda, MD based Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. Northwest Biotherapeutics, Inc. reported that its annual Total Revenue declined from $2.41 million in 2019 to $1.29 million in 2020, and that its Net Loss increased from $20.29 million in 2019 to $529.82 million in 2021.
Shares of Northwest Biotherapeutics, Inc. (OTC: NWBO) closed on April 27, 2021, at $1.52 per share.
Those who purchased shares of Northwest Biotherapeutics, Inc. (OTC: NWBO), have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Northwest Biotherapeutics, Inc. (OTC:NWBO) Investor Notice: Investigation over Potential Wrongdoing
An investigation on behalf of investors in Northwest Biotherapeutics, Inc. (OTC:NWBO) shares over potential wrongdoing at Northwest Biotherapeutics, Inc. was announced.